org, that describes the benefits of
low dose Naltrexone [LDN]). It
is also thought to act by restoration of the body's normal production of endorphins, and this is thought to be the major therapeutic action of LDN. Although Naltrexone is an FDA approved drug, LDN has not yet been approved by the FDA.
Some patients apparently benefit from LDN, and there is a list of testimonials. There are, however, some cautionary declarations about LDN:
1.